Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Cloopen Group Holding Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
118
118
86.1
80.4
78.6
76.6
Cost of revenue
70.6
75.4
53.3
51.6
49.7
55.6
Gross profit
47
42.7
32.8
28.8
28.9
21
Research and development
26.5
46.7
47.3
31.3
24.2
19.9
Selling and marketing
32.4
47.1
38.5
32
25.7
20.3
General and administrative
31.6
60.5
46.3
26.9
12.9
15.9
Operating expenses
90.5
186
174
90.3
56
56.1
Operating income
-43.4
-143
-141
-61.5
-27.1
-35.1
Interest expense
2.19
0.06
0.06
Interest income
5.78
1.52
Pre-tax income
-76.4
-140
-142
-58.2
-20.2
-34.3
Income tax
0.25
1.75
-0.05
-0.08
-0.04
-0.12
Net income to minority interests
1.17
-0.09
-0.15
-0.37
-0.56
0.08
Net income
-588
-142
-141
-57.7
-19.6
-34.2
EBITDA
-42.1
-141
-139
-60.3
-26.1
-34.4
EPS, basic
-6.91
-3.08
-0.44
-0.18
-0.06
-0.11
EPS, diluted
-6.91
-3.08
-0.44
-0.18
-0.06
-0.11
Shares, basic (weighted)
85.1
295
322
322
323
323
Shares, diluted (weighted)
85.1
295
322
322
323
323
Balance sheet
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
45.5
103
76.4
53.2
87.7
46.4
Short-term investments
20
59.7
59.5
39.9
51.4
Receivables
35.1
24.9
20.3
Other current assets
21.3
21.4
15.7
15.4
16.4
16
Total current assets
135
425
311
230
197
177
Property, plant and equipment
2.52
2.21
2.09
1.46
1.12
0.87
Lease right-of-use assets
2.37
1.97
1.48
2.02
Goodwill
19.1
7.89
7.67
7.46
7.78
Intangible assets
0.31
7.6
2.46
2.01
1.59
1.33
Long-term investments
10.1
20
8.49
7.61
7.41
7.62
Other non-current assets
0.59
0.49
0.66
0.5
0.5
0.42
Total assets
148
475
335
251
216
197
Accounts payable
20.2
23.2
17.7
12.4
13.1
18.6
Deferred revenue
14.7
44.9
52.2
51.2
41.9
42.8
Short-term debt
3.07
0.86
Total current liabilities
119
110
108
82.5
69.7
77.3
Long-term debt
1.26
Lease liabilities
0.94
0.31
0.65
0.54
Other non-current liabilities
0.52
0.13
0
Total liabilities
122
113
109
83
70.4
77.8
Total debt
1.26
Paid-in capital
1,737
1,622
1,579
1,538
1,607
Retained earnings
-753
-1,326
-1,366
-1,385
-1,366
-1,461
Treasury stock
-12.8
-17.5
-17
-16.6
-17.3
Other comprehensive income
32
-36.4
-11.4
-8.07
-7.72
-9.1
Shareholders' equity
-721
362
227
169
147
120
Minority interests
0.36
-0.17
-0.48
-0.84
-1.37
-1.35
Total equity
-721
362
226
168
146
119
Total liabilities and equity
148
475
335
251
216
197
Cash flow statement
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-76.6
-142
-141
-58.1
-20.1
-34.1
Depreciation and amortization
1.32
1.65
2.01
1.24
1.05
0.72
Stock-based compensation
17.9
43.6
15.6
3.13
1.96
1.89
Deferred income tax
-0.13
0.8
-1.28
-0.06
-0.05
-0.06
Change in receivables
-5.9
5.39
0.18
-3.96
5.28
-3.86
Cash from operations
-34.3
-37.4
-82.2
-72.7
-24.7
-33
Capital expenditures
-0.84
-1.16
-0.85
-0.11
-0.4
-0.11
Acquisitions
-31.9
-16.9
-1.26
Purchases of investments
-20
-50.7
-3.97
-30.4
-62.1
Cash from investing
-14.7
-285
51
49.5
63.1
-11.5
Debt repaid
-16.3
-1.16
Stock issued
4.22
Cash from financing
70.1
384
-7.65
Exchange rate effect
-0.56
-5.69
20.1
2.83
-1.63
1.85
Net change in cash
20.6
55.8
-18.8
-20.4
36.7
-42.7
Free cash flow
-35.2
-38.5
-83.1
-72.8
-25.1
-33.2
Interest paid
0.25
0.05
0.07
Income taxes paid
0.02
0.05
0.05
0.01
0
0
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $2.65 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
27.4%
Gross profit / revenue.
Operating margin
-45.9%
Operating income / revenue.
EBITDA margin
-44.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-44.7%
Pre-tax income / revenue.
Net margin
-44.7%
Net income / revenue.
FCF margin
-43.3%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-43.1%
Cash from operations / revenue.
Return on equity (ROE)
-25.6%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-16.6%
Net income / average total assets.
Return on invested capital (ROIC)
-41.6%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
26.0%
Research and development expense / revenue.
Stock-based pay / revenue
2.5%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.1%
Capital expenditures / revenue.
D&A / revenue
0.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-2.5%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-3.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-8.2%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-27.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-13.8%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-14.9%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-18.3%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-19.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-9.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-16.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
5.8%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
30.6%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.29x
Current assets / current liabilities.
Quick ratio
1.27x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.27x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.11
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.24
Revenue / diluted weighted shares.
FCF per share
-$0.10
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.10
Cash from operations / diluted weighted shares.
Book value per share
$0.37
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
What was Cloopen Group Holding Ltd's revenue in fiscal 2025?
Cloopen Group Holding Ltd reported revenue of $76.6M for fiscal 2025, 2.5% lower than the year before.
Was Cloopen Group Holding Ltd profitable in fiscal 2025?
No. It reported a net loss of $34.2M.
How much free cash flow did Cloopen Group Holding Ltd generate in fiscal 2025?
Cash from operations of $33.0M minus capital expenditures of $113.0K left free cash flow of -$33.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.